COVID19



One of the UK’s leading infectious disease biotech companies has announced a breakthrough in laboratory trials of a new drug to treat COVID-19 and new variants of the disease, such as the ...

A new programme of work led by the University of Liverpool is seeking to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population,...

Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that following assessments by the UK accreditation service (UKAS), it has received ISO 15189:2012 accreditation...

The team will develop a computer program to screen mutations for potentially increased transmission and potential immune escape

They say science gathers knowledge faster than society gathers wisdom. However, this past year we have become quick to learn as we have become accustomed to living with the COVID-19 pandemic...

2021 STEM Survey

Jul 9th 2021

SRG have once again partnered with New Scientist Jobs to produce their annual STEM industry survey. This is an invaluable insight for all those working or hiring within the STEM sectors. Dow...

A medical laboratory company recently contacted Aport to project manage the movement of a Covid-19 testing laboratory including all its equipment and instruments into storage.

Yourgene Genomic Services providing COVID-19 services to MHC’s new Boots partnership

Aptamer Group and Mologic extend collaboration to CE mark Aptamer Group's SARS-CoV-2 rapid antigen test

With the effects of the pandemic continuing to cause many deaths, it is right that pharma companies have put IP on the back burner for now, but it shouldn’t be forgotten.

The new scheme aims to help businesses affected by Covid-19 and can be used for any legitimate business purpose, including managing cashflow, investment and growth. It is designed to appeal ...

University of Bradford professor is leading UK-wide awareness campaign